These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4788392)

  • 1. [The level of follicle stimulating activity in precancer and cancer of the breast].
    Iskakova KI; Mezinova NN
    Vopr Onkol; 1973; 19(9):15-9. PubMed ID: 4788392
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary estrogen excretion in preneoplastic breast diseases].
    Kozhnazarova IuS; Mezinova NN; Remizova MG; Ikhsanova ST
    Vopr Onkol; 1972; 18(10):23-6. PubMed ID: 4662530
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of age and menopause duration on the excretion of steroid hormones in precancerous conditions and cancer of the breast].
    Bogdanova AG
    Vopr Onkol; 1974 Oct; 20(7):13-8. PubMed ID: 4277856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Markers of malignant growth as a component of morphologic pattern in human biological fluids].
    Shatokhina SN; Shabalin VN
    Vopr Onkol; 2010; 56(3):293-300. PubMed ID: 20804050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucuronic acid, glucuronyltransferase and estrogens in breast cancer and precancer].
    Al'pert AE; Zhandarova LF
    Vopr Onkol; 1978; 24(10):66-70. PubMed ID: 213895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urine levels to total gonadotropins and follicle-stimulating hormone in precancerous diseases and cancer of the cervix uteri].
    Mezinova NN; Orazbaeva LK
    Akush Ginekol (Mosk); 1970 Mar; 46(3):63-4. PubMed ID: 5484025
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum and urine glucuronic acid in breast cancer and precancer].
    Al'pert AE; Lunts AM
    Vopr Onkol; 1971; 17(11):28-31. PubMed ID: 5157636
    [No Abstract]   [Full Text] [Related]  

  • 8. The estriol quotient in fibrocystic disease, a high-risk group for breast cancer.
    Bagli NP; Shah PN; Mistry SS
    Indian J Cancer; 1980 Dec; 17(4):201-4. PubMed ID: 7228103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Excretion of pituitary and steroid hormones in breast cancer following pituitary irradiation].
    Izmaĭlova GE; Sharoukhova KS; Goncharova MG; Kuz'mina ZV; Murav'eva NI
    Vestn Akad Med Nauk SSSR; 1972; 27(10):36-9. PubMed ID: 4641120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics in the correlation of ovarian cycle hormones in mastopathy and breast cancer].
    Kuz'mina ZV; Shapoukhova KS; Murav'eva NI; Goncharova MG; Molodyk AA
    Vestn Akad Med Nauk SSSR; 1979; (2):60-4. PubMed ID: 419869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Examination of the luteotropic hormone activity of blood and urinary steroid excretion in diseases of the breast].
    Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
    Arch Geschwulstforsch; 1969; 34(2):179-87. PubMed ID: 5407886
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mastopathy and breast cancer].
    Berndt H; Marwitz S
    Arch Geschwulstforsch; 1968; 32(1):137-48. PubMed ID: 5692645
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urine catecholamine content in patients with malignant and benign breast neoplasms].
    Arsiriĭ SA
    Vopr Onkol; 1969; 15(7):50-3. PubMed ID: 5811140
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary androgen excretion and the etiology of breast cancer.
    Bulbrook RD
    J Natl Cancer Inst; 1972 Apr; 48(4):1039-42. PubMed ID: 5023673
    [No Abstract]   [Full Text] [Related]  

  • 17. Copper, zinc and superoxide dismutase in precancerous, benign diseases and gastric, colorectal and breast cancer.
    Magálová T; Bella V; Brtková A; Beno I; Kudlácková M; Volkovová K
    Neoplasma; 1999; 46(2):100-4. PubMed ID: 10466433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tissue factor levels in patients with breast and colorectal cancer.
    Lwaleed BA; Chisholm M; Francis JL
    J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peculiarities of hormonal metabolism in men with gynecomastia and breast cancer].
    Lazarev NI; Sharoukhova KS; Murav'eva NI; Smirnova KD; Goncharova MG
    Vestn Akad Med Nauk SSSR; 1969; 24(6):28-35. PubMed ID: 5373263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the biological and immunological activity in preparations of follicle stimulating hormone].
    Morell M; Butt WR; Ayanz A
    Rev Esp Fisiol; 1971 Mar; 27(1):45-8. PubMed ID: 5565756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.